Skip to content

Pfizer PFE Gross Carrying Amount

Gross Carrying Amount at other companies

Amgen logo
AmgenAMGN
Viatris logo
ViatrisVTRS
Biogen logo
BiogenBIIB
Abbott logo
AbbottABT
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+5.0%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.68B+11.1%
Enterprise value$206.35B+9.2%
P/E11.9×
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's gross carrying amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's gross carrying amount?
Pfizer (PFE) reported gross carrying amount of $104.78B in Q1 2026.
How has Pfizer's gross carrying amount changed year-over-year?
Pfizer's gross carrying amount increased by 1.3% year-over-year, from $103.4B to $104.78B.
What is the long-term trend for Pfizer's gross carrying amount?
Over 5 years (2020 to 2025), Pfizer's gross carrying amount has grown at a 6.3% compound annual growth rate (CAGR), from $76.76B to $104.01B.